Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))

EVE trial investigators

doi:10.1016/j.jtha.2024.12.011

Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))

EVE trial investigators

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret the omission of author Micah J Mooberry from the original author list. This has now been corrected as above. The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	756
Number of pages	1
Journal	Journal of Thrombosis and Haemostasis
Volume	23
Issue number	2
DOIs	https://doi.org/10.1016/j.jtha.2024.12.011
State	Published - Feb 2025
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/j.jtha.2024.12.011

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))'. Together they form a unique fingerprint.

Cite this

EVE trial investigators (2025). Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011)). Journal of Thrombosis and Haemostasis, 23(2), 756. https://doi.org/10.1016/j.jtha.2024.12.011

Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011)). / EVE trial investigators.
In: Journal of Thrombosis and Haemostasis, Vol. 23, No. 2, 02.2025, p. 756.

Research output: Contribution to journal › Comment/debate › peer-review

EVE trial investigators 2025, 'Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))', Journal of Thrombosis and Haemostasis, vol. 23, no. 2, pp. 756. https://doi.org/10.1016/j.jtha.2024.12.011

EVE trial investigators. Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011)). Journal of Thrombosis and Haemostasis. 2025 Feb;23(2):756. doi: 10.1016/j.jtha.2024.12.011

EVE trial investigators. / Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’ : [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011)). In: Journal of Thrombosis and Haemostasis. 2025 ; Vol. 23, No. 2. pp. 756.

@article{f21b892b32a649e3946c6af36ddd4bf1,

title = "Corrigendum to {\textquoteleft}Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial{\textquoteright}: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))",

abstract = "The authors regret the omission of author Micah J Mooberry from the original author list. This has now been corrected as above. The authors would like to apologise for any inconvenience caused.",

author = "\{EVE trial investigators\} and McBane, \{Robert D.\} and Loprinzi, \{Charles L.\} and Tyler Zemla and Alfonso Tafur and Kristen Sanfilippo and Liu, \{Jane Jijun\} and Garcia, \{David A.\} and James Heun and Krishna Gundabolu and Onitilo, \{Adedayo A.\} and Usha Perepu and Drescher, \{Monic R.\} and Stanislav Henkin and Damon Houghton and Aneel Ashrani and Henny Billett and Mooberry, \{Micah J.\} and McCue, \{Shaylene A.\} and Lee, \{Minji K.\} and Le-Rademacher, \{Jennifer G.\} and Wysokinski, \{Waldemar E.\}",

note = "Publisher Copyright: {\textcopyright} 2024 International Society on Thrombosis and Haemostasis",

year = "2025",

month = feb,

doi = "10.1016/j.jtha.2024.12.011",

language = "English (US)",

volume = "23",

pages = "756",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’

T2 - [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))

AU - EVE trial investigators

AU - McBane, Robert D.

AU - Loprinzi, Charles L.

AU - Zemla, Tyler

AU - Tafur, Alfonso

AU - Sanfilippo, Kristen

AU - Liu, Jane Jijun

AU - Garcia, David A.

AU - Heun, James

AU - Gundabolu, Krishna

AU - Onitilo, Adedayo A.

AU - Perepu, Usha

AU - Drescher, Monic R.

AU - Henkin, Stanislav

AU - Houghton, Damon

AU - Ashrani, Aneel

AU - Billett, Henny

AU - Mooberry, Micah J.

AU - McCue, Shaylene A.

AU - Lee, Minji K.

AU - Le-Rademacher, Jennifer G.

AU - Wysokinski, Waldemar E.

PY - 2025/2

Y1 - 2025/2

N2 - The authors regret the omission of author Micah J Mooberry from the original author list. This has now been corrected as above. The authors would like to apologise for any inconvenience caused.

AB - The authors regret the omission of author Micah J Mooberry from the original author list. This has now been corrected as above. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85212840046

UR - https://www.scopus.com/pages/publications/85212840046#tab=citedBy

U2 - 10.1016/j.jtha.2024.12.011

DO - 10.1016/j.jtha.2024.12.011

M3 - Comment/debate

C2 - 39709266

AN - SCOPUS:85212840046

SN - 1538-7933

VL - 23

SP - 756

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

IS - 2

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this